Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anesthetic 1
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Topical, Ophthalmic
01
Overview
Anesthetic 1 is a topical anesthetic administered as eye drops, primarily used to numb the surface of the eye. It is employed in ophthalmic procedures, such as laser-assisted in situ keratomileusis (LASIK) surgery, to provide local anesthesia and ensure patient comfort during the intervention.
- Other names
- Anesthetic 1 eye dropsAnesthetic1 eye dropsAnesthetic-1 eye drops
02
Targets
SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN3A (Sodium channel protein type 3 subunit alpha)SCN9A (Sodium channel protein type 9 subunit alpha)
Beyond the preview
Go deeper on Anesthetic 1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anesthetic 1.